(b)(4).There was no reported device malfunction and the product was not returned.The reported patient effects of hemorrhage and pain are known observed and potential patient effects as listed in the herculink elite instructions for use.Although a conclusive cause for the reported patient effect and the relationship to the product, if any, cannot be determined, there is no indication of a product quality issue with respect to manufacture, design or labeling.
|
It was reported that the herculink plus stent was implanted in the renal artery in (b)(6) 2001.The patient began having flank/kidney pain, lower extremity swelling, abdominal and low back swelling, hematuria and dysuria in (b)(6) 2014.The cause of these issues is unknown at this time.The patient will continue to obtain medical care and diagnostics from his physicians.The hematuria and dysuria ended around (b)(6) 2015.No additional information was provided.
|